Page 5 of 7 · 162 questions tagged tirzepatide.
Numbers first: a GLP-1 receptor agonist · mazdutide. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
For reference: liraglutide · tirzepatide. I am trying to choose between two options that are usually discussed as though only one exists. I am not optimising for…
Conditions: ecnoglutide · retatrutide. I would like the axes of comparison first and the recommendation second. I have tried the first option and it works; the…
I have two third-party reports in front of me. Both say "identity confirmed by ESI-MS" and both include a spectrum, but the spectra look nothing like the single clean…
I received a mapping report on tirzepatide. It states "sequence coverage: 100%" in bold at the top, and then the fragment table has exactly two entries in it.…
The specifics, since they change the answer: SURMOUNT-OSA · semaglutide. I would like to know whether this claim survives contact with evidence. If the answer is…
Setup, so nobody has to ask: STEP 5 · a GLP-1 receptor agonist. This is asserted often enough that I assumed it was established, and then I went looking for the…
Stated plainly: SURPASS-3 · cagrilintide. This is asserted often enough that I assumed it was established, and then I went looking for the source. I have searched the…
Setup, so nobody has to ask: SUSTAIN-6 · cagrilintide. This is asserted often enough that I assumed it was established, and then I went looking for the source. I have…
What I have: TRIUMPH-3 · orforglipron. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am…
The case in front of me: STEP 1 · tirzepatide. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and…
Details up front: cagrilintide · semaglutide. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
Details up front: PIONEER-4 · dulaglutide. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am…
The specifics, since they change the answer: ATTAIN-1 · semaglutide. Somebody stated this to me confidently and I would like to check it before repeating it. I would…
The case in front of me: SURMOUNT-2 · oral semaglutide. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries…
The case in front of me: STEP 1 · oral semaglutide. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and…
What I am working with: REDEFINE-1 · mazdutide. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary sources all…
The particulars: REDEFINE-1 · ecnoglutide. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested that", I would…
Numbers first: mazdutide · semaglutide. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a defensible reason…
What I have: mazdutide · retatrutide. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a defensible reason…
Setup, so nobody has to ask: PIONEER-1 · mazdutide. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary sources all…
For reference: tirzepatide · tirzepatide. I am trying to choose between two options that are usually discussed as though only one exists. I am not optimising for…
The specifics, since they change the answer: liraglutide · mazdutide. I am trying to choose between two options that are usually discussed as though only one exists.…
The specifics, since they change the answer: STEP 5 · survodutide. I would like to know whether this claim survives contact with evidence. If the answer is "nobody…